Welcome to our dedicated page for Senestech news (Ticker: SNES), a resource for investors and traders seeking the latest updates and insights on Senestech stock.
SenesTech, Inc. develops and commercializes fertility-control products for managing animal pest populations, with current products focused on rat and mouse populations. Its product names include ContraPest, Evolve Rat, and Evolve Mouse, which are used within pest-management programs as alternatives or complements to traditional rodent-control methods.
Company news centers on Evolve commercialization, e-commerce and direct-to-consumer sales channels, Amazon marketplace management, field-study data on rodent activity, product approvals in international markets, quarterly and annual financial results, capital runway commentary, and executive leadership or board governance updates.
SenesTech (NASDAQ: SNES) will release its second quarter 2026 financial results, for the period ended June 30, 2026, after market close on Wednesday, August 5, 2026. A conference call and live webcast to review the results will follow at 5:00 p.m. Eastern time.
SenesTech (NASDAQ: SNES) reported successful use of Evolve Rat Birth Control at a 400-acre farm in Dalhart, Texas. The agricultural operation, which uses underground drip irrigation, saw onsite-estimated rodent activity decline about 80%, with fewer leaks and reduced irrigation tape damage after several months of Evolve deployment.
SenesTech (NASDAQ: SNES) appointed veteran sales executive Jack Karabees as Executive Vice President of Sales. He will lead the sales organization, focusing on revenue growth, broader market penetration and stronger customer relationships.
Karabees has decades of B2B sales leadership and has already consulted for SenesTech on commercial strategy.
SenesTech (NASDAQ: SNES) announced a distribution agreement to expand its Evolve Rodent Birth Control products into Bermuda via Animal and Garden House. The company highlights Bermuda's tightly regulated, environmentally sensitive island ecosystem and positions Evolve as a non-lethal, fertility-based rodent control option. Existing regional deployments include the U.S. Virgin Islands and Belize.
SenesTech (NASDAQ: SNES) announced that its board revised the proposed amendment to the 2018 Equity Incentive Plan ahead of the June 9, 2026 annual meeting. The revised proposal would add 1.2 million shares for future equity awards, reduced from 1.7 million previously contemplated.
Stockholders who already voted in favor of Proposal No. 3 will be deemed to support the revised terms unless they change their vote.
SenesTech (NASDAQ: SNES), a company focused on fertility control for managing animal pest populations and maker of EPA-compliant Rodent Birth Control products, will participate in the virtual Lytham Partners Spring 2026 Investor Conference on Thursday, May 28, 2026.
The company will deliver a webcast presentation at 2:30 p.m. ET, accessible via the conference home page or direct webinar link. The webcast will be available for replay, and management will also hold virtual one-on-one meetings with investors during the event.
SenesTech (NASDAQ: SNES) reported Q1 2026 revenue of $493,000, up 2% year over year, with a company-record gross margin of 68.6%. Direct-to-consumer sales grew 42% to $194,000 and subscription revenue rose 44% to $56,000, while B2B revenue increased 57% to $298,000.
Net loss widened to $2.1 million, including $443,000 of severance and one-time legal costs. April 2026 e-commerce sales grew 163% year over year to $146,000, with subscription revenue up 198%. Michael Edell was appointed CEO, supporting the in-house Amazon and recurring revenue strategy.
SenesTech (NASDAQ: SNES) will report first quarter 2026 financial results for the period ended March 31, 2026, after market close on Tuesday, May 12, 2026. A conference call to review results is scheduled the same day at 5:00 p.m. Eastern, with a live webcast and a replay available for at least 90 days.
SenesTech (NASDAQ: SNES) appointed Michael Edell as President and Chief Executive Officer, effective May 6, 2026, and updated Board leadership to support commercial growth. Edell previously served as interim COO since October 2025 after consulting mid-2025 and led operations, Amazon sales for Evolve, and early subscription rollout.
The company said it will not refill the interim COO role and announced Matthew Szot as Board Chair while Dr. Jamie Bechtel moves to committee chair roles.
SenesTech (NASDAQ: SNES) reported 2025 results with revenue up 20% to $2.2M, driven by strong e-commerce growth and a transition to direct Amazon management. Gross margin improved to 62.5% from 54.1% and adjusted EBITDA loss narrowed to $5.3M. Cash and short-term investments totaled $8.6M, providing runway into approximately Q2 2027. Operational highlights included e-commerce revenue +88% YoY, field validation showing up to a 79% decline in rat activity at one site, regulatory approval in New Zealand, and a CEO transition with an Interim Executive Chair appointed.